1765 related articles for article (PubMed ID: 34293314)
1. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
2. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
[TBL] [Abstract][Full Text] [Related]
3. Metal and essential element concentrations during pregnancy and associations with autism spectrum disorder and attention-deficit/hyperactivity disorder in children.
Skogheim TS; Weyde KVF; Engel SM; Aase H; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Caspersen IH; Hornig M; Haug LS; Villanger GD
Environ Int; 2021 Jul; 152():106468. PubMed ID: 33765546
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
[TBL] [Abstract][Full Text] [Related]
5. Modeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study.
Shin HM; Bennett DH; Calafat AM; Tancredi D; Hertz-Picciotto I
Environ Res; 2020 Jul; 186():109514. PubMed ID: 32353786
[TBL] [Abstract][Full Text] [Related]
6. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
[TBL] [Abstract][Full Text] [Related]
7. Association between early-childhood exposure to perfluoroalkyl substances and ADHD symptoms: A prospective cohort study.
Kim JI; Kim BN; Lee YA; Shin CH; Hong YC; Døssing LD; Hildebrandt G; Lim YH
Sci Total Environ; 2023 Jun; 879():163081. PubMed ID: 36972880
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study.
Oh J; Bennett DH; Calafat AM; Tancredi D; Roa DL; Schmidt RJ; Hertz-Picciotto I; Shin HM
Environ Int; 2021 Feb; 147():106328. PubMed ID: 33387879
[TBL] [Abstract][Full Text] [Related]
9. Childhood exposure to per- and polyfluoroalkyl substances and neurodevelopment in the CHARGE case-control study.
Oh J; Shin HM; Kannan K; Busgang SA; Schmidt RJ; Schweitzer JB; Hertz-Picciotto I; Bennett DH
Environ Res; 2022 Dec; 215(Pt 2):114322. PubMed ID: 36108719
[TBL] [Abstract][Full Text] [Related]
10. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
11. The Association between Prenatal Per- and Polyfluoroalkyl Substances Exposure and Neurobehavioral Problems in Offspring: A Meta-Analysis.
Yao H; Fu Y; Weng X; Zeng Z; Tan Y; Wu X; Zeng H; Yang Z; Li Y; Liang H; Wu Y; Wen L; Jing C
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767045
[TBL] [Abstract][Full Text] [Related]
12. Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies.
Forns J; Verner MA; Iszatt N; Nowack N; Bach CC; Vrijheid M; Costa O; Andiarena A; Sovcikova E; Høyer BB; Wittsiepe J; Lopez-Espinosa MJ; Ibarluzea J; Hertz-Picciotto I; Toft G; Stigum H; Guxens M; Liew Z; Eggesbø M
Environ Health Perspect; 2020 May; 128(5):57002. PubMed ID: 32378965
[TBL] [Abstract][Full Text] [Related]
13. Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability.
Lyall K; Yau VM; Hansen R; Kharrazi M; Yoshida CK; Calafat AM; Windham G; Croen LA
Environ Health Perspect; 2018 Jan; 126(1):017001. PubMed ID: 29298162
[TBL] [Abstract][Full Text] [Related]
14. Exposure to perfluoroalkyl substances and neurodevelopment in 2-year-old children: A prospective cohort study.
Luo F; Chen Q; Yu G; Huo X; Wang H; Nian M; Tian Y; Xu J; Zhang J; Zhang J;
Environ Int; 2022 Aug; 166():107384. PubMed ID: 35834943
[TBL] [Abstract][Full Text] [Related]
15. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems.
Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Bellinger DC; Webster TF; White RF; Sagiv SK
Environ Res; 2021 Nov; 202():111621. PubMed ID: 34237332
[TBL] [Abstract][Full Text] [Related]
16. No association between maternal and child PFAS concentrations and repeated measures of ADHD symptoms at age 2½ and 5 years in children from the Odense Child Cohort.
Dalsager L; Jensen TK; Nielsen F; Grandjean P; Bilenberg N; Andersen HR
Neurotoxicol Teratol; 2021; 88():107031. PubMed ID: 34563660
[TBL] [Abstract][Full Text] [Related]
17. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
[TBL] [Abstract][Full Text] [Related]
19. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
[TBL] [Abstract][Full Text] [Related]
20. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
